Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Adamis Pharmaceuticals Corporation (ADMP) shares

Learn how to easily invest in Adamis Pharmaceuticals Corporation shares.

Adamis Pharmaceuticals Corporation is a drug manufacturers-specialty & generic business based in the US. Adamis Pharmaceuticals Corporation stocks (ADMP.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.05 – the same closing value as a week prior. Adamis Pharmaceuticals Corporation employs 116 staff and has a trailing 12-month revenue of around $17.8 million.

How to buy shares in Adamis Pharmaceuticals Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ADMP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Adamis Pharmaceuticals Corporation stock price (NASDAQ:ADMP)

Use our graph to track the performance of ADMP stocks over time.

Adamis Pharmaceuticals Corporation shares at a glance

Information last updated 2022-01-25.
Latest market close$0.61
52-week range$0.55 - $1.74
50-day moving average $0.71
200-day moving average $0.91
Wall St. target price$1.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.42

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
Wealthsimple Trade
Finder Rating:
3.9 / 5
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
3.8 / 5
$4.99 - $9.99
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
4.1 / 5
Min. $1.00, Max. 0.5%
Stocks, Bonds, Options, ETFs, Currencies, Futures
CIBC Investor's Edge
Finder Rating:
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Finder Rating:
4.2 / 5
$4.95 - $9.95
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get up to $5,000 cash back. Conditions apply. Offer ends March 1, 2022.

Compare up to 4 providers

Online stock trading

Is it a good time to buy Adamis Pharmaceuticals Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Adamis Pharmaceuticals Corporation price performance over time

Historical closes compared with the close of $0.61 from 2022-01-25

1 week (2022-01-19) 0.11%
1 month (2021-12-23) -4.46%
3 months (2021-10-23) N/A
6 months (2021-07-27) -41.35%
1 year (2021-01-27) -54.81%
2 years (2020-01-24) -12.41%
3 years (2019-01-25) 3.08
5 years (2017-01-26) 3.2

Adamis Pharmaceuticals Corporation financials

Revenue TTM $17.8 million
Gross profit TTM $1.6 million
Return on assets TTM -57.21%
Return on equity TTM -168.77%
Profit margin 0%
Book value $0.23
Market capitalisation $91 million

TTM: trailing 12 months

Adamis Pharmaceuticals Corporation share dividends

We're not expecting Adamis Pharmaceuticals Corporation to pay a dividend over the next 12 months.

Have Adamis Pharmaceuticals Corporation's shares ever split?

Adamis Pharmaceuticals Corporation's shares were split on a 1:17 basis on 12 December 2013. So if you had owned 17 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Adamis Pharmaceuticals Corporation shares – just the quantity. However, indirectly, the new 1600% higher share price could have impacted the market appetite for Adamis Pharmaceuticals Corporation shares which in turn could have impacted Adamis Pharmaceuticals Corporation's share price.

Adamis Pharmaceuticals Corporation share price volatility

Over the last 12 months, Adamis Pharmaceuticals Corporation's shares have ranged in value from as little as $0.55 up to $1.74. A popular way to gauge a stock's volatility is its "beta".

ADMP.US volatility(beta: 1.23)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Adamis Pharmaceuticals Corporation's is 1.2276. This would suggest that Adamis Pharmaceuticals Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Adamis Pharmaceuticals Corporation overview

Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy and respiratory disease in the United States. The company's product candidates comprise Symjepi Injection pre-filled syringe (PFS) for use in the emergency treatment of acute allergic reactions, including anaphylaxis; dry powder inhaler products consisting of fluticasone for the treatment of asthma; beclomethasone, a metered dose inhaler product for the asthma; and naloxone injection product candidates for the treatment of opioid overdose. It also offers APC400, a tempol gel use of reducing radiation dermatitis in patients undergoing treatment for cancer; and APC410 for the treatment of respiratory diseases, including asthma, respiratory syncytial virus, influenza, and COVID-19. In addition, the company provides corticosteroids, hormone replacement therapies, hospital outsourcing products, injectables, urological preparations, topical compounds for pain, and men's and women's health products; and veterinary pharmaceutical products for animals. Adamis Pharmaceuticals Corporation was founded in 2006 and is headquartered in San Diego, California. .

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site